Brief: Initiator Pharma Secures Bridge Financing Of SEK 5 Million

Initiator Pharma A/S

13/08/2019 11:04

Aug 13 (Reuters) - Initiator Pharma A/S  INIT.TE :
    * SECURES BRIDGE FINANCING IN PREPARATION OF A CLINICAL
PHASE 2A
TRIAL FOR THE CANDIDATE DRUG IP2018
    * CLINICAL PHASE 2A TRIAL REGARDING IP2018 IS EXPECTED TO
BEGIN IN
EARLY 2020.
    * WITH THIS BRIDGE FINANCING, COMPANY IS ABLE TO CONDUCT
ACTIVITIES FOR ADDED VALUE BEFORE SEEKING MORE LONG-TERM
FUNDING.
    * CLINICAL PHASE 2A TRIAL REGARDING IP2018 IS EXPECTED TO
BEGIN IN
EARLY 2020.
    * COMPANY HAS SECURED BRIDGE FINANCING OF SEK 5 MILLION
    * BRIDGE FINANCING IS VALID UNTIL FEBRUARY 2020 AT AN
INTEREST
RATE OF 2 PER CENT PER MONTH, AND IS INTENDED TO BE FULLY OR
PARTIALLY REPAID IN CASH.

Source text for Eikon:  ID:nWkr5PT19P 
Further company coverage:  INIT.TE 

 (Gdynia Newsroom)
 ((gdynia.newsroom@thomsonreuters.com; +48 587720920;))